Список литературы

1. Арабидзе Г.Г., Арабидзе Гр. Г. Антигипертензивная терапия и половая функция у мужчин // Клин. Фарм. Тер. - 1999. -N 3. - С. 49-52.

2. Амарантова Л.Г., Берг М.Д., Ховаева Я.Б., Головской Б.В. Влияние лизиноприла на функцию эндотелия и гладких мышц периферических сосудов у больных артериальной гипертензией // Лечебное дело. - 2005. -№3.-С. 42-46.

3. Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т. Эндотелиальная функция при сердечной недостаточности: возможности терапии ингибиторами ангиотензин-превращающего фермента // Кардиология. - 2001. - №5. - С. 30-45.

4. Варшавский СВ., Лахмотко А.А. Комплексная терапия больных психогенной эректильной дисфункцией. - В кн .: Материалы IX Всерос. съезда урологов: - М., 1997. - С. 449-450.

5.Васильченко Г.С.О. Частотных характеристиках стержневых сексопатологических синдромов у мужчин // Актуальн. вопросы сексопатологии.,Тез.докл.Шсесоюзн. конф. Сексопатологов. - Уфа-1986,— С. 9-11.

6. Гамидов СИ., Иремашвили В.В. Эректильная дисфункция и сердечнососудистые заболевания: новый взгляд на старую проблему // Кардиоваскулярная терапия и профилактика. - 2006. - №6. - С. 123-128.

7. Гамидов СИ., Мазо Е.Б., Овчинников Р.И. Эректильная дисфункция у больных с ишемической болезнью сердца // Терапевтический Архив. - 2004. - №10.-С. 75-80.

8. Иремашвили В.В. Значение исследования эндотелиальной функции у больных эректильной дисфункцией: Дис. ... к-та мед.наук. - Москва., - 2006.

9. Калинченко С.Ю., Козлов Г.И., Гончаров Н.П., Новолодская Ю. В.: Возрастные изменения гипоталамо-гипофизано-тестикулярной оси у мужчин. Вторая научная конференция с международным участием посвященная 80 —

145летию с дня рождения профессора М. Г. Колпакова. Россия, Новосибирск, 15-17 октября 2002г.( Русский медицинский журнал . том 14 № 26 ( 278) 2006.

10. Камалов А. А., Дорофеев С. Д., Ефремов Е. А. Кардиоваскулярные аспекты эректильной дисфункции // Consilium medicum. - 2004. - №5. - С. 7-10.

11. Калинченко С.Ю., Козлов Г.И., Андреева Е.Н. Комплексный подход к лечению эректильной дисфункции у мужчин с ожирением //Эндокринология. - 2002-№4.- С. 50-53.

12. Лоран О.Б., Щеплев П.А., Нестеров С.Н., Кухаркин С.А. Современные методы диагностики и лечения эректильных дисфункций // Русский Медицинский Журнал. - 2000. - № 3. - С. 130-134.

13. Мазо Е.Б., Гамидов СИ., Иремашвили В.В. К вопросу о патогенезе артериогенной эректильной дисфункии // Врачебное сословие. - 2006. - №1-2.-С.4-7.

14. Малая Л.Т., Корж А.Н., Балковая Л.Б. Эндотелиальная дисфункция при патологии сердечно-сосудистой системы. - Харьков.: ТОРСИНГ, 2000. - С. 432.

15. Марков X. М. Молекулярные механизмы дисфункции сосудистого эндотелия // Кардиология. — 2005. — №12. — С. 62-61.

16. Мазо Е.Б., Гамидов СИ., Иремашвили В.В. Роль эндотелиальной дисфункции кавернозных артерий в патогенезе эректильной дисфункции у больных метаболическим синдромом // Тезисы научно-практической конференции, посвященной 300-летию основания Главного военного клинического госпиталя имени академика Н.Н.Бурденко. М., - 2006. - С. 119.

17. Мазо Е.Б., Гамидов СИ., Овчинников Р.И., Иремашвили В.В. Этиология, патогенез, диагностика и лечение эректильной дисфункции у пожилых // Фарматека. - 2005. - №4/5 (100). - С. 40-45.

18. Мазо Е.Б, Гамидов СИ, Овчинников РИ, Иремашвили ВВ. Новые аспекты патогенеза, профилактики и лечения эректильной дисфункции у больных

146после радикальной простатэктомии // Consilium Medicum - 2004. - 6 (7). -С.506-509.

19. Мастере У., Джонсон В., Колодны Р. О любви и сексе. В 2 ч., ч. 2 // Пер.сангл.СПб., Ретур-1991. - С. 296.

20. Мазо Е.Б., Зубарев А.Р., Жуков О.Б. Ультразвуковая диагностика васкулогенной эректильной дисфункции. М.: Медицина — 2003 г.

21. Мычка В. Б. и др. Медикаментозное лечение ожирения больных с метаболическим синдромом // Кардиоваскулярная терапия и профилактика. -2005.-№4.-С. 79-84.

22. Мазо Е.Б., Дмитриев Д.Г., Гамидов СИ., Овчинников Р.И. Фармакотерапия эректильной дисфункции // Русский Медицинский Журнал. -2001.-9:1077-1078.

23. Щеплев П.А., Тополянский А. В., Жиленко В .В:, Носовицкий П.Б. Эректильная дисфункция и сердечно-сосудистые заболевания // Медицинская кафедра . - 2002. -№2. - С. 68-73.

24. AmetovA.S., Teodorovich O.V., Kondrat'eva L.V., PopovaAI.U. Some aspects of erectile dysfunction pathogenesis and treatment in patients with obesity.

25. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences // BJU Int. - 1999. -V. 84. -P.50-56.

26. Araujo AB, Mohr В A, McKinlay JB. Changes in sexual function in middle -aged and older men: Longitudinal data from the Massachusetts male aging study // J Am Geriatr Soc. - 2004. -V. 52. - 1502 P.9.

27. Ahn HS, Park CM, Lee SW. The clinical relevance of sex hormone levels and sexual activity in the ageing male // BJU Int. - 2002. -V. 89 -P.526-530.

28. Akkus E, Carrier S, Baba К et al. Structural alterations in the tunica albuginea of the penis: impact of Peyronie's disease, aging and impotence // BJU hit. -1997.-V.79-P.47-51.

29. Amenta F, Cavallotti C, De Rossi M et al. Vasoactive intestinal polypeptide levels and distribution in the penis of old rats // J Neural Transm. - 1987. -V. 70-P.137-142.

30. Andrew PJ, Mayer B. Enzymatic function of nitric oxide synthases // Cardiovasc Res. - 1999. -V. 43-P.521-526.

31. Agarwal A, Jain DC. Male sexual dysfunction after stroke // J Ass Physicians India. -1989. -V. 37-P.505-508.

32. Ageing and endothelial dysfunction // European Heart Journal Supplement. -2002.-V.4-P.8-P.17.

33. Araujo AB, Durante R, Feldman HA et al. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional result-from the Massachusetts Male Aging Study. Psychosom Med. - 1998.- V.60-P.458-462.

34. Altinkilic B, Hauck EW, Weidner W. Evaluation of penile perfusion by color-coded duplex sonography in management of erectile dysfunction // World J Urol. — 2004.-V. 22-P. 361-364.

35.Braun M, Wassmer G, Klotz T et al. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey1. Int f Impot Res. - 2000. -V. 12-P.305-311.

36. Berner M, Althof SE, Goldstein I, Cappelleri JC et al. Relationship between erection hardness and confidence in men with erectile dysfunction treated with sildenafil citrate // J Sex Med. - 2008. - V. l(suppl 149). -1. - Abstract MP-026.

37. Bemelmans BL, Meuleman EJH, Doesburg WH et al. Erectile dysfunction in diabetic men: the neurological factor revisited // J Urol. - 1994.-V. 151-P.884-886.

38. Bansal S. Sexual dysfunction in hypertensive men. A critical revuew of the literature // Hypertens. - 1988. -V.29 - P. 1-10.

39. Bruckert E, Giral P, Heshrnati HM, Turpin G. Men treated with hypoiipidaemic drags complain more frequently of erectile dysfunction // J Clin Pharm Ther. - 1996. -V. 21- P.89-94.

40. Bellamy MF, McDowell IFW, Ramsey MW et al. Oral folate enhances endothelial function in hyperhomocysteinaemic subjects // Eur J Clin Invest. — 1999. - Vol. 29. -P. 659-662.

41. Bivalacqua TJ, Champion HC5 Abdel-Mageed AB et al. Gene transfer of preprocalcitonin gene-related peptide restores erectile function in the aged rat // Biol Reprod. - 2001. - V.65. - P.1371-1376.

42.Costa P, Avances C, Wagner L. [Erectile dysfunction: knowledge, wishes and attitudes. Results of a French study of 5.099 men aged 17 to 70] // Prog. Urol. — 2003.-Vol. 13.-Nl.-P. 85-91.

43. CA Allan, BJG Srauss, RI Mclachlan. Body composition, metabolic syndrome and testosterone in ageing men // International Journal of Impotence Research. — 2007-V.19-P. 448-457.

44. Carrier S, Nagaraju P, Morgan DM et al. Age decreases nitric oxide synthase containing nerve fibers in the rat penis // J Urol. - 1997. - V.I57- P. 1088-1094.

45. Chung WS, Park YY, Kwon SW. The impact of aging on penile hemodynamics in normal responders to pharmacological injection: a Doppler sonographic study // J Urol. - 1997. -V. 157-P.2129-2132.

46.Chew KK, Earle CM, Stuckey BGA et al. Erectile dysfunction in general medicine practice: prevalence and clinical correlates// Int J Impot Res. — 2000. — V.12-P.41-45.

47. Costa CC, Soares RS, Castela AC, Adaes SA et al. Increased endothelial apoptotic cell density in human diabetic erectile tissue - comparison with clinical data // J Sex Med. - 2008. - V. l(suppl 149). -1. - Abstract PD-043.

48. Cook JP. Does ADMA cause endothelial dysfunction? // Arterioscler Thromb Vase Biol. - 2000. - V. 20. - P. 2032-2037.

49. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress // Circ Res. - 2000. - V. 87. - P. 840-844.

50. Celermajer DS, Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis // Lancet. — 1992. - V. 340. - P. 1111-1115.

51. Celermajer DS, Sorensen KE, Georgakopoulos D et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium - dependent dilation in healthy young adults. ?? Circulation - 1993- V. 88-P. 2149-2155.

52. Carr AC, Zhu BZ, Frei B. Potential Antiatherogenic Mechanisms of Ascorbate (Vitamin C) and o-Tocopherol (Vitamin E) // Circ Res. - 2000. - Vol. 87. - P. 349-354.

53. Carson CC. Sildenafil citrate treatment for erectile dysfunction: rate of adverse events decreases with time// J Urol. - 2002. -V 167 (suppl) -P.179-188.

54. Chia SJ, Ramesh K, Earnest A. Clinical application of prognostic factors for patients with organic causes of erectile dysfunction on 100 mg of sildenafil citrate //IntJ Urol.-2004.-V. 11.-P. 1104-1109.

55. Claes HIM, Van Poppel H. The use of sildenafil, tadalafil and vardenafil in clinical practice// J Sex Med. - 2005. - V.2(suppl. 1) - PS.5-3.

56. Carson C.C. The efficacy of sildenafil citrate (Viagra) in clinical population: an update / C.C Carson, L. Burnet [et al.] // Urology.-2002. -V. 60, N2, supp. 2-P 12-27.

57. Carson C.C. Efficacy, safety, and treatment satisfaction of tadalafil versus piacebo in patients with erectile dysfunction evaluated at tertiary-care academic centers// Urolpgy. -2005. -V.65., N.2. -P.353-359.

58. Champion HC, Bivalacqua TJ, Hyman AL et al. Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat// Proc Natl Acad Sci USA . -1999. -V. 96-P.I 1648-11659. 59.Derogatis LR, Burnett Al. The epidemiology of sexual dysfunction // J Sex Med. - 2008. -V.5-P.289-300.

60. Duff GL, McMillan GC. Pathology of atherosclerosis // Am J Med. - 1951. -V. 11.-P. 92-108.

61. Dimmeler S, Fleming I, Fisslthaler В et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation // Nature. - 1999. - V. 399. -P. 601-605.

62. Derby Ca et al. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk // Urology. - 2000. -V. 56- P.302-306.

63.Derby C.A., Barbour M.M., Hume A.L., McKinlay J.B. Drag therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort // Pharmacotherapy. - 2001. - V. 21. - N 6. - P. 676-683.

64. Doshi SN, McDowell IF, Moat SJ et al. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide? // Arterioscler Thromb Vase Biol. - 2001. - V. 21. - P. 1196 -1202.

65. Esposito К et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized trial // JAMA .-2004. -V.29-P.2978-2984.

66. Eardley I. Attitudes toward treatment of erectile dysfunction: results from the males study / I. Eardley, R. Rosen, W. Fisher [et al.] // Cur. Med. Res. Opin. - 2004. -V. 20, N.5-P. 605-615.

67. E1-Sakka Al. Efficacy of sildenafil citrate in treatment of erectile dysfunction: effect of type 2 diabetes // Eur Urol. - 2004. - V. 46. - P. 503-509.

68. Erectile Dysfunction and Mental health in General Population of older Men // International Sex Med. - 2009. -V. 6-P.505-512.

69. Feldman HA, Goldstein I, Hatzichristou DG et al. Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study // J Urol. -1994. -V.151-P.54-61.

70. Feldman HA, Johannes CB, Araujo AB et al. Low dehydroepiandrosteron and ischemic heart disease in middle aged men: prospective results from the Massachusetts Male Aging Study// Am J Epidem. -2001. -V.I 53-P.79-89.

71.Ferrini M, Magee TR, Vernet D et al. Aging-related expression of inducible nitric oxide synthase and markers of tissue damage in the rat penis// Biol Reprod. - 2001.-V. 64- P. 974-978.

72. Fedele D, Coscelli C, Santeusanio F et al. Erectile dysfunction in diabetic subjects in Italy// Gruppo Italiano Studio Defecit Erettile nei Diabetici. Diabetes Care. - 1998. -V. 21 -P.1973-1976.

73. Fuster V, Badimon L, Badimon JJ et al. The pathogenesis of coronary artery disease // N Engl J Med. - 1992. - V. 326. - P. 242-250.

74. Furchgott RF, Zawadski TV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine // Nature. - 1980. - V. 288. - P. 373—376Ahn HS, Park CM, Lee SW. The clinical relevance of sex hormone levels and sexual activity in the ageing male// BJU Int. - 2002. - V.89-526-530.

75. Fowler C, The neurology of male sexual dysfunction and its investigation by clinical neurophysiological method // BJU. - 1998. -V.81-P.6.

76. Fogari R, Zoppi A. Effects of antihypertensive therapy on sexual activity in hypertensive men // Curr. Hypertens. Rep. - 2002. - V. 4. - N 3. - P. 202-210.

77. Francis SH, Corbin JD. Molecular mechanisms and pharmacokinetics of phosphodiesterase-5 antagonists// Cur Urol Rep. - 2003. -V. 4-P.457-465.

78. Giagulli VA. Kaufan JM. Vermeulen A. Pathogenesis of the decreased androgen levels in obese men// Eur J Endocrinol Metab. — 1994. —V.79-P.997—1000.

79. Gimbrone MA, Topper JN, Nagel T et al. Endothelial Dysfunction, Hemodynamic Forces, and Atherogenesis // Ann. N.Y. Acad. Sci. — 2000. — V. 902-P. 230-240.

80. Green JS, Holden ST, Bose P et al. An investigation into the relationship between prostate size, peak urinary flow rate and male erectile dysfunction// Int J Impot Res.-2001.-V. 13-P.322-326.

81.Guay A.T. Optimizing response to phosphodiesterase therapy: impact of risk — factor management // J . Androl. - 2003 . - V. 24,N6-P. 59-62.

82.Ganz P, Vita JA. Testing endothelial vasomotor function. Nitric oxide, a multipotent molecule // Circulation. - 2003. - V. 108. - P. 2049-2053. 83. Goldstein I, Young JM, Fisher I et al. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter, double-blind, placebo-controlled, fixed-dose study// Diabetes Care.- 2003. -V.26-P.777-783.

84.Gooren L. Testosterone supplementation: why and for whom? // Aging Male.— 2003.-V.6-P.184-199.

85. Humman SM, Tsitouras PD, Reproductive hormones in aging men. 1. Meusurment of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic-gonodotrotin//J Clin. Endocrinol Metob. - 1980. -V. 51-P. 35-40.

86. Harbitz ТВ. Morphometric studies of Leydig cells in elderly men with special reference to histology of prostate . An analysis in autopsy series// Act Pathol Microbiol Scand. - 1973. -V.81-P.301-314.

87. Hak AE, Witteman JC, de Jong FH. Et al. Low levels of endogenous androgen increase the risk of atherosclerosis in elderly men; the Rotterdam study // J Clin Endocrinol Metab. - 2002. -V.87- P. 3632-3639.

88. Hickey MJ. Role of inducible nitric oxide synthase in the regulation of leucocyte recruitment// Clin Sci. -2001. -V. 100-P.1-9.

89. Haas CA, Seftel AD, Razmjouei К et al. Erectile dysfunction in aging: upregulation of endothelial nitric oxide synthase // Urology. - 1998. -V.51-P.516-522.

90. Heine RJ. Current therapeutic options in type 2 diabetes // Eur J Clin Invest. — 1999. - (suppl)V. 29-P. 17-24.

91. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction // J Clin Invest. - 1997. - V. 100. - P. 2153-2157.

92. Hatzichristou D, Hatzimouratidis K, Bekas M et al. Diagnostic steps in the evaluation of patients with erectile dysfunction // J Urol. -2002. - V. 168. - P. 615-620.

93. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction // J Clin Invest. - 1997. - V. 100. - P. 2153-2157.

94. Hsu G-L et.: The three dimensional structure of the human tunica albuginea: Anatomical and ultrastructure levels// hit J Impotence Res. — 1992.-V.4-P.117.

95. Hamdy О, Ledbury S, Mullooly С et al. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome // Diabetes Care. - 2003. - V. 26 - P. 2119-2125.

96. Hellstrom W, Gittelman M, Karlin G et al. Sustained efficacy and tolerability of vardenafil (Levitra®), a highly potent, selective phosphodiesterase-5 inhibitor, in men with erectile dysfunction: results of a randomised, double-blind, 26-week placebo-controlled pivotal trial // Urology. - 2003. - V.26-P.777-783.

97. Hansen D, Astrap A, Toubro S, Finer N, Kopelman P, Hilsted J, Rossner S, Saris W, Van GaalL, James W, Goulder For The STORM Study Group M. Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance// Int J Obes Relat Metab Disord. - 2001. -V. 25(4) -P.496-501.

98. Ignarro LJ, Byms RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possess pharmacologic and chemical properties identical to those of NO radical // Circ Res. - 1987. - V. 61. - P. 866-879.

99. Jiang X, Meuleman EJ, Wijkstra G, Wagner G. Coipus cavernosum electromyography during morning naps in healthy volunteers: further evidence that coipus cavernosum potentials reflect sympathetically mediated activity. // J Urol.-2005-V. 174(5)-P.1917-20.

100. Joannides R, Haefeli WE, binder L et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo // Circulation. -1995.-V. 91.-P. 1314-1319.

101. Jones RW, Rees RW, Minhas S et al. Oxygen free radicals and the penis // Expert Opin Pharmacother. - 2002. - V. 3. - P. 213-225.

102. Kinsey AC, Pomeroy WB, Martin CE. Sexual Behavior of the human male. Philadelphia: W.B. Saunders, 1948.

103. Kaufman JM, Vermeulen A, Declining gonadal function in elderly men // Baillieres Clin Endocrinol Metab. - 1997. -V 11- P.289-309.

104. Karacan I, Williams R, Thornby J, Salis TJ. Sleep-related penile tumescence as a function of age // Am J Psychiatry. - 1975. -V. 132. -P. 932-937.

105. Katlowitz NM, Albano GJ, Morales P Golimbu M. Potentiation og drag-induced erection with audiovisual sexual stimulation. // Urology -1993 -V. 41-P. 431^34.

106. Korantzopoulos P, Galaris D. The protective role of vitamin С on endothelial dysfunction // J Clin Basic Cardiol. - 2003. - V. 6. - P. 3-5.

107. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors // JAMA. - 1999. -V. 281 -P.537-544.

108. Lizza EF, Rosen RC. Definition and classification of erectile dysfunction: Report of the Nomenclature Committee of the International Society of Impotence Research // Int J Impot Res. - 1999. - V. 11. - P. 141-143.

109. Logcope С Effect of human chorionic gonadotropin on plasma steroid levels in young and old men // Steroids. - 1973. -V. 21-P. 583-590.

110. Lugg JA, Rajfer J. Gonzales-Cadavid NF. Digydrotestosterone is active androgen in maintenance of nitric oxidemediated penile erection in the rat // Endocrinology. - 1995. -V. 136-P. 1495-150.

111. Lin JS, Lin YM, Chow NH et al. Novel image analysis of corpus cavernous tissue in impotent men // Urology. - 2000. -V. 55-P.252-256.

112. Little WC, Constantinescu M, Applegate RS et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? // Circulation. — 1988. —V. 78. —P. 1157—1166.

113. Lue TF, Tanagho EA,. Physiology of erection and pharmacological management of impotence //J Urology-1987-Vol. 137-P. 829-836.

114. Leungwattanakij S, Flynn V, Hellstrom WJG. Intracavernosal injection and intraurethral therapy for erectile dysfunction // Urol Clin Notli Am. - 2001.-V.28(2)-P.343-354.

115. Meuleman EJ. Erectile dysfunction: prevalence and effect on the quality of life; Boxmeer study // Neder Tijdschr Geneesk. - 2001. -V. 145-P.576-581.

116. Melman A, Gingell JC. The epidemiology and pathophysiology of erectile dysfunction // J Urol. - 1999. - V. 161. - P. 5-11.

117. McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction // Int J Impot Res. - 2000. - Vol. 12 (suppl.). - P. 6-10.

118. Morales A, Heaton JPW, Carson CC. Andropause: a misnomer for a true clinical entity // J Urol. -2000. -V. 163-P.705-712.

119. Mulligan T, Iranmanesh A. Kerzner R et al. Two -week pulsatile gonadoropin releasing hormone infusion unmasks dual ( hypothalamic and Leydig cell) defect in the healthy aging male gonadotropic axis // Eur J Endocinol.-1999. -V.141-P.257-266.

120. Mills TM, Relly CM, Lewis RW. Androgens and penile erection: a review // J Androl. - 1996. -V.17-P. 633-638.

121. Moon DG, Lee, Kim YW, et al. Effect of TCDD on corpus cavernosum histology and smooth muscle physiology // Int J Impot Res.- 2004.-V.16-P.224.

122. Moreland RB. Pathophysiology of erectile dysfunction: the contributions of trabecular structure to function and the role of functional antagonism // Int J Impot Res. - 2000. - suppl. V.12-P.39-45.

123. May AG, DeWeese JA, Rob CG. Changes in sexual function following operation on the abdominal aorta // Surgery. - 1969. - V.65-P.41—47.

124. McCulloch DK, Campbell IW, Wu FC et al. The prevalence of diabetic impotence // Diabetologia. - 1980. -V.18-P.279-288.

125. Montorsi F, Briganti A, Salonia A et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease // Eur Urol. -2003. - V. 44. - P. 360-365.

126. Montorsi P, Roumeguere T, Montorsi F et al. Is there a link between erectile dysfunction and coronary artery disease? // EAU Update series. - 2004. - V. 2. -P. 43-48.

127.Maas R, Wenske S, Zabel Met al. Elevation of Asymmetrical Dimethylarginine (ADMA) and Coronary Artery Disease in Men with Erectile Dysfunction // Eur Urol. - 2005. - V. 48. - P. 1004-1012.

128. Maas R; Schwedhelm E; Albsmeier J; Boger RH. The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function // Vase Med. - 2002. - V. 7. - P. 213-225.

129. Macfarlane GH, Botto H, Sagnier PP et al. The relationship between sexual life and urinary condition in the French community // J Clin Epidemiol. —1996.-V.49-P.1171-1176.

130. McConnell J, Roehrborn C, Bautista О et al. The long-term effects of doxazosin, finasterid and the combination on the clinical progression of benign prostatic hyperplasia // N Eng J Med. - 2003. -V. 349-P.23 87-2398.

131. Montorsi F. Assessment, diagnosis, and investigation of erectile dysfunction // Clin Cornerstone. - 2005. - V. 7. - P. 29-35.

132. Morley JE, Charlton E, Patric P et al. Validation of screening questionnaire for androgen deficiency in aging male // Metabolism .-2000. -V. 49(9)-P.1239-1242.

133. Melman A. An intermediate approach to impotence evaluation // Contemp Urol. -1995. -V.7-P.14-17.

134. Maiorana A,O Driscoll G, Cheetham С et al. The effect of combined aerobic and resistence exercise training on vascular function in type 2 diabetes // J Am Coll Cardiol. - 2001. -V. 38 -P . 860-866.

135. Mullen MJ, Clarkson P, Donald AE et al. Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: a randomized, double-blind study // J Am Coll Cardiol. - 1998. - V. 31. - P. 1330-1335.

136. Muiesan ML, Salvetti M, Monteduro С et al. Effect of treatment on flow-dependent vasodilation of the brachial artery in essential hypertension // Hypertension.- 1999. -V. 33.-P. 575-580.

137. Martinez-Jabaloyas JM, Gil-Salom M, Villamon-Fort R. Prognostic factors for response to sildenafil in patients with erectile dysfunction // Eur Urol. - 2001. -V. 40.-P. 641-646.

138. Montorsi F, Salonia A, Deho F et al. Pharmacological management of erectile dysfunction //Br J Urol. - 2003. -V. 91-P.446-54.

139. Montorsi F, Padma-Nathan H, Buvat J et al. Earliest time to onset of action leading to successful intercourse with vardenafil determined in an at-home setting: a randomized, double-blind, placebo-controlled trial //J Sex Med.-2004.-V.l-P.168-178.

140. NIH consensus development panel on impotence: NIH consensus conference. Impotence // JAMA. - 1993. - V. 270. - P. 83-90.

141. Nehra A, Moreland RB. Neurologic erectile dysfunction //Urol Clin Noth Am. -2001. -V. 28-P.289-308.

142. O'Keefe M, Hunt DK. Assessment and treatment of impotence// Med Clin N Am. - 1995.-V. 79-P. 415-434.

143. Pourmand G, Alidaee MR, Rasuli S et al. Do cigarette smokers with erectile dysfunction benefit from stopping? a prospective study // BJU Int. - 2004. - V. 94. -P. 1310-1313.

144. Penson DF, Latini DM, Lubeck DP et al. Do impotent men with diabetes have more sever erectile dysfunction and worse quality of life than the general population of impotent patients? // Diabetes Care. - 2003. -V. 26-P. 1093-1099.

145. Padma-Nathan H, Christ G, Adaikan G et al. Pharmacotherapy for erectile dysfunction //J Sex Med. - 2004. -V. 1-P. 128-140.

146. Pereira Cunill JL, Astorga Jimenez R. Obesity pharmacological treatment // Rev Clin Esp. - 2005. -V.205(4) -P. 175-7.

147. Rowland DL, Greenleaf W, Mas M et al. Penile and finger sensory thresholds in young, aging, and diabetic males //Arch Sex Behav. - 1989. -V. 18-P.1-5.

148. Rosen R, O'Leary M, Altwein J et al. LUTS and male sexuality: Findings of the MSAM-7// Int J Impot Res. - 2002. -V. 14 (suppl.) - AC3.8.

149. Rosen,R. С. Riley, A. , Wagner, G., Osterloh, .l.H KirkpatrikJ. and Mishra, A: The international index of erectile function (IIEF).a multidimensional scale for assessment of erectile dysfunction // Urology. - 1997. -V.49-P.822.

150. Ralph D, McNicholas Т. 1Ж management guidelines for erectile dysfunction // BMJ. - 2000. - V. 321. - N 19. - P. 499-503.

151. Raina R, Lakin MM, Agarwal A et al. Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy // Urology. - 2004. - V. 63. - P. 960-966.

152. Seftel AD. Erectile dysfunction in the elderly: epidemiology, etiology and approaches to treatment //J Urol. - 2003-V. 169-P. 1999-2007.

153. Schiavi RC, Schreiner-Engel P, White D, Mandeli J. The relationship between pituitary-gonadal function and sexual behavior in healthy aging men // Psychsom Med. - 1991. - V53-P.363-367.

154. Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator //Heart—2003. —V. 89-P.251-254.

155. Surdacki S, Nowicki M, Sanmann J et al. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension // J Cardiovasc Pharmacol. - 1999. - V. 33. - P. 652-658.

156. Shafik A, Sibai O, Shafik I. Transcutaneus electrocavernosography: a tool for elctromyographic activity of the corpora cavemosa // J Urol.—2005.—V 174(2) —P. 629-631.

157. Sasaki S, Higashi Y, Nakagawa К et al. A low calorie diet improves endothelium - dependent vasodilation in obese patients with essential hypertension // Am J Hypertens. - 2002. - V. 15- P.302- 309.

158. Stroes ESG, van Faassen ЕЕ, Yo M et al. Folic acid reverts dysfunction of endothelial nitric oxide synthase // Circ Res. - 2000. - V. 86. - P. 1129 -1134.

159. Tistouras PD. Bulat T. The aging male reproductive system // Endocrinal Metab clin North Am. - 1995. - V. 24- P.297- 315.

160. Traish AM, Park K, Dhir V, et al. Effects of castration and androgen replacement on erectile function in a rabbit model // Endocrinology.- 1999. -V.140-P.1861.

161. Traish AM, Munarriz R, O'Connell L, et al. Effects of medical or surgical castration on erectile function in an animal model // J Androl. - 2003. - V. 24-P.381.

162. Travison T.G. The natural progression and remission of erectile dysfunction : result from the Massachusetts Male Aging study // J. Urol. - 2007. - V. 43, N5. -P.544-551.

163. TorgersonJS, HauptmanJ, BoldrinMN, SjostromL. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients // Diabetes Care. - 2004. - V. 27(1) -P. 155- 161.

164. Taddei S, Virdis A, Ghiadoni L et al. Different effects of a calcium-antagonist and a beta-blocker on nitric oxide availability in essential hypertensive patients // J Hypertens. - 1999. - V. 17. - P. 129.

165. United Nations department of economic and social affairs. Population division. World population prospects: the 2000 revision. No. EO1.XII.12. New York: United Nations, 2001.

166. Ulker S, McKeown PP, Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities // Hypertension. - 2003. - V. 41. - P. 534- 539.

167. Vermeulen A. Andropause //Maturitas. - 2000. - V. 34 - P.5- 10. 168.Van den Beld AW, Bots ML, Janssen JA, et al. Endogenes hormones and carotid atherosclerosis in elderly men// Am J Epidemiol. - 2003 -V. 157-25- 31.

169. Vanegas JP, Raviv G, Kiss К et al. Intracavernous collagen analysis in impotence // Acta Urol Belg. - 1996. - V. 64- 7- 11.

170. Vane J, Anggard E, Botting R. Regulatory function of the vascular endothelium // N Engl J Med. - 1990. - V. 323. - P. 27- 36.

171. Vanhoutte PM. Endothelial Control of Vasomotor Function // Circ J. - 2003. -V. 67.-P. 572-575.

172.Vita JA, Treasure CB, Nabel EG et al. Coronary vasomotor responce to acetylcholine relates to risk factors for coronary artery disease // Circulation. — 1990. -V. 81. -P. 491-497.

173. Virag R. Flow-dependent dilatation of the cavernous artery. A potential test of penile NO content // J Mai Vase. - 2002. - V. 27. - P. 214-217.

174.Virag R, Floresco J, Richard С Impairment of shear-stress-mediated vasodilation of cavernous arteries in erectile dysfunction // Int J Impot Res. - 2004. -V. 16.-P. 39-42.

175. World Health Organization/ Life in the 21st century: A vision for all. (World Health Report). Geneva: World Health Organization; 1998.

176. Warburton AL, Santer RM. Sympathetic and sensory innervation of the urinary tract in young adult and aged rats: a semi-quantitative histochemical and immunohistochemical study // Histochem J. - 1994. -V. 26-P. 127-131.

177. Wespes E, Amar E, Hatzichristou D et al. EAU Guidelines on Erectile Dysfunction: An Update // Eur Urol. - 2006. - V. 49 - P. 806-815.

178. Woo KS, Chook P, Lolin YI, Sanderson JE et al. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia // J Am Coll Cardiol. -1999. - V. 34. - P. 2002-2006.

179. Wespes E. Guidelines on erectile dysfunction / E. Wespes, E. Amar, D.G. Hatzichristou [et al.] .Amsterdam: European Association of Urology // 2006.-P.27.

180. Yetik-Anacak G, Catravas JD. Nitric oxide and the endothelium: history and impact on cardiovascular disease // Vase Pharmacol. - 2006. - V. 45.-P. 268-276.

181. Zakaria L, Anastasiadis AG, Shabsigh R. Common condition of the aging male. Erectile dysfunction, .benign prostatic hyperplasia. Cardiovascular disease and depression. Int. Urol. Nephrol 2001; 33: 283-92Seftel AD. Erectile dysfunction in the elderly: epidemiology, etiology and approaches to treatment// J Urol.-2003.-V. 169-1999-2007.

182.Zeiher AM, Drexler H, Wollschlager H et al. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis // Circulation. - 1991. - Vol. 83. -P. 391-401. Boger RH, Bode-Boger SM, Szuba A et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia // Circulation. - 1998. - V. 98. - P. 1842-1847.

Абдыкеримов Б.К. Особенности диагностики и лечения эректильной дисфункции у пожилых мужчин

Назад | Оглавление

Похожие материалы

• Эректильная дисфункция у пожилых мужчин

• Влияние фармакотерапии эректильной дисфункции на кавернозную электрическую активность и гемодинамику (Овчинников Р.И.,)

• Влияние регуляторного приема ингибиторов фосфодиэстеразы 5 типа на эректильную и эндотелиальную функции у больных с артериогенной эректильной дисфункцией (Гасанов Р.В.)

• Оценка влияния лечения эректильной дисфункции на качество жизни больных (Живов А.В.)

Дата публикации: 15 января 2017

.

	Жизнь после травмы спинного мозга